BROADWAY LICENSING GLOBAL ANNOUNCES ACQUISITION OF THE COMEUPPANCE AND FLEX
The Comeuppance, centers on a long-dispersed group of friends who reunite after years apart to reconnect and confront hidden truths during a pre-20th high school reunion. Filled will tension and humor, The Wrap calls Jacobs-Jenkins' new play "mesmerizing". Additional Jacobs-Jenkins titles also represented by the company, and available for license, include Gloria and An Octoroon.
Appropriate, another Jacobs-Jenkins' title, is now making its critically acclaimed
Flex, a play by Jones, tells a coming-of-age story about a group of teenage basketball players in rustic
"We are thrilled to come out swinging in 2024 with the acquisition of a fresh batch of brilliant and contemporary titles," says
Learn more about all titles at: www.broadwaylicensing.com.
ABOUT BROADWAY LICENSING GROUP
Broadway Licensing Global and its family of imprints (Dramatists Play Service, Playscripts, and Stageworks) is the global leader in theatrical licensing and distribution. The iconic works represented epitomize the greatest collection of authors, composers, lyricists, and underlying rights holders across the globe including
MEDIA CONTACT
Public Relations at Interdependence | press@broadwaylicensing.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/broadway-licensing-global-announces-acquisition-of-the-comeuppance-and-flex-302040240.html
SOURCE Broadway Licensing Global
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FLORIDA SOUTHERN COLLEGE HONORS DISTINGUISHED ALUMNUS LT. GEN. DONALD L. KERRICK WITH ROTC BUILDING DEDICATION AND STATEWIDE RAIDER COMPETITION
- BNB News: BNB Bounces Off $709 as Sellers Tire Out, and Pepeto Buyers Chase a Run
- Dogecoin Price Prediction: Can DOGE Revisit $0.50 as Remittix Tests a Payments-First Alternative Before Launch?
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share